At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 51 enrolled
Drug / intervention
IV ibuprofen +1 moredrug
Likely dose
IV ibuprofen 800 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study to Determine the Efficacy of Intravenous Ibuprofen for Pain Control Following Arthroscopic Knee Surgery
In Brief
A Phase 4 clinical trial evaluating IV ibuprofen and IV ketorolac for Arthroscopic Knee Surgery. Completed, enrolled 51 participants across 1 site.
Detailed Summary
The intent of this study is to assess the analgesic efficacy of IV ibuprofen when administered at induction of anesthesia. Results from this pilot study will be used to design and determine the appropriate statistical power for a larger, multi-center randomized study.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArthroscopic Knee Surgery
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJul 2012
Enrollment StartSep 2012
Primary CompletionDec 2012
Study CompletionJan 2013
TodayJul 2026
First PostedJul 26, 2012
Enrollment StartSep 1, 2012
Primary CompletionDec 1, 2012
Study CompletionJan 1, 2013
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 13.9 years ago
Interventions
IV ibuprofendrug
800 mg intravenous ibuprofen administered intravenously over 10 minutes.
IV ketorolacdrug
30 mg ketorolac for patients \< 65 years of age (15 mg ketorolac for patients \> 65 years of age) administered intravenously over no less than 15 seconds